↓ Skip to main content

Cochrane Database of Systematic Reviews

Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV.

Overview of attention for article published in Cochrane database of systematic reviews, February 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
34 Mendeley
Title
Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV.
Published in
Cochrane database of systematic reviews, February 2012
DOI 10.1002/14651858.cd007276.pub2
Pubmed ID
Authors

Omeje I, Okwundu CI

Abstract

The current recommended antiretroviral treatment is a highly active antiretroviral therapy (HAART). Although HAART has been associated with improved clinical response to treatment, issues of adherence and viral resistance are major challenges limiting its success. There is a need for an effective and safe first-line regimen, to cope with the ever-increasing incidence of non-adherence and primary resistance. A more recent first-line treatment regimen consists of Tenofovir (TDF, 300 mg) + Emtricitabine (FTC, 200 mg) + Efavirenz (EFV, 600 mg).

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ethiopia 1 3%
Unknown 33 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 15%
Lecturer 4 12%
Student > Bachelor 4 12%
Student > Ph. D. Student 4 12%
Student > Doctoral Student 3 9%
Other 8 24%
Unknown 6 18%
Readers by discipline Count As %
Medicine and Dentistry 11 32%
Nursing and Health Professions 4 12%
Pharmacology, Toxicology and Pharmaceutical Science 3 9%
Agricultural and Biological Sciences 2 6%
Immunology and Microbiology 2 6%
Other 4 12%
Unknown 8 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2012.
All research outputs
#14,598,119
of 22,663,150 outputs
Outputs from Cochrane database of systematic reviews
#10,548
of 12,296 outputs
Outputs of similar age
#160,035
of 250,716 outputs
Outputs of similar age from Cochrane database of systematic reviews
#157
of 217 outputs
Altmetric has tracked 22,663,150 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,296 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 250,716 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 217 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.